Download PDF
J Reconstr Microsurg 2018; 34(09): 701-707
DOI: 10.1055/s-0038-1642623
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Prospective Evaluation of Health-Related Quality of Life following Lymphaticovenular Anastomosis for Upper and Lower Extremities Lymphedema

Marzia Salgarello
1   Department of Plastic and Reconstructive Surgery, Policlinico Universitario Agostino Gemelli, Rome, Italy
,
Maria Lucia Mangialardi
1   Department of Plastic and Reconstructive Surgery, Policlinico Universitario Agostino Gemelli, Rome, Italy
,
Valentina Pino
1   Department of Plastic and Reconstructive Surgery, Policlinico Universitario Agostino Gemelli, Rome, Italy
,
Stefano Gentileschi
1   Department of Plastic and Reconstructive Surgery, Policlinico Universitario Agostino Gemelli, Rome, Italy
,
Giuseppe Visconti
1   Department of Plastic and Reconstructive Surgery, Policlinico Universitario Agostino Gemelli, Rome, Italy
› Author Affiliations
Further Information

Publication History

07 September 2017

05 March 2018

Publication Date:
24 April 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Background Lymphedema is a progressive disease that negatively affects body image and physical, psychological, and social functions. There is lack of evidence in the present literature about the impact of super microsurgical lymphaticovenular anastomosis (LVA) on health-related quality of life (HRQoL). The aim of this prospective study is to report the outcomes of patients' HRQoL after LVA for lower and upper extremities lymphedema.

Methods Between September 2015 and February 2017, 74 patients with upper or lower limb lymphedema (ULL or LLL) underwent LVA at our center. Quality of life (QoL) was assessed by lymphedema QoL questionnaire (LyMQoL), which is a validated disease-specific instrument to measure the impact of lymphedema on patient's lives, covering four domains: function, body image, symptoms, and mood. All patients were evaluated preoperatively, 1 month after surgery, and every 3 months up to 1 year. Additionally, we evaluated the episodes of lymphangitis and the need for conservative therapy before and after surgery.

Results After a mean follow-up of 8.5 months (range: 2–21 months), we observed an increase of 2.3 points in the overall QoL average for upper limb and 2.6 points for lower limb (p  <  0.001). A statistically significant improvement in all four domains (p  <  0.01) was reported after surgery, being present from the first postoperative months for both upper and lower extremities.

Conclusion Our study shows that lymphaticovenular anastomosis improves HRQoL in patients affected by ULL and LLL. Additionally, both a reduction of episodes of lymphangitis and a decrease in the need of conservative therapy were observed in this cohort of patients.

Keywords

lymphedema - quality of life - lymphaticovenular anastomosis
 

  • References

  • 1 Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 2008; 26 (21) 3536-3542
    CrossrefPubMedGoogle Scholar
  • 2 Abu-Rustum NR, Alektiar K, Iasonos A. , et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006; 103 (02) 714-718
    CrossrefPubMedGoogle Scholar
  • 3 Pusic AL, Cemal Y, Albornoz C. , et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv 2013; 7 (01) 83-92
    CrossrefPubMedGoogle Scholar
  • 4 Bulley C, Gaal S, Coutts F. , et al. Comparison of breast cancer-related lymphedema (upper limb swelling) prevalence estimated using objective and subjective criteria and relationship with quality of life. BioMed Res Int 2013; 2013: 807569
    PubMedGoogle Scholar
  • 5 van de Pas CB, Biemans AA, Boonen RS, Viehoff PB, Neumann HA. Validation of the lymphoedema quality-of-life questionnaire (LYMQOL) in Dutch patients diagnosed with lymphoedema of the lower limbs. Phlebology 2016; 31 (04) 257-263
    CrossrefPubMedGoogle Scholar
  • 6 Keeley V, Crooks S, Locke J, Veigas D, Riches K, Hilliam R. A quality of life measure for limb lymphoedema (LYMQOL). J Lymphoedema 2010; 5: 26-37
    Google Scholar
  • 7 Alliot F. Launois lymphedema and quality of life. Rev Med Interne 2002; 23 (Suppl 3): 431s-435s
    CrossrefPubMedGoogle Scholar
  • 8 Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118 (08) 622-629
    PubMedGoogle Scholar
  • 9 Keeley V. Quality of life assessment tools in chronic oedema. Br J Community Nurs 2008; 13 (10) S22-S27
    PubMedGoogle Scholar
  • 10 Patel KM, Lin CY, Cheng MH. A prospective evaluation of lymphedema-specific quality-of-life outcomes following vascularized lymph node transfer. Ann Surg Oncol 2015; 22 (07) 2424-2430
    CrossrefPubMedGoogle Scholar
  • 11 Gratzon A, Schultz J, Secrest K, Lee K, Feiner J, Klein RD. Clinical and psychosocial outcomes of vascularized lymph node transfer for the treatment of upper extremity lymphedema after breast cancer therapy. Ann Surg Oncol 2017; 24 (06) 1475-1481
    CrossrefPubMedGoogle Scholar
  • 12 De Brucker B, Zeltzer A, Seidenstuecker K, Hendrickx B, Adriaenssens N, Hamdi M. Breast cancer-related lymphedema: quality of life after lymph node transfer. Plast Reconstr Surg 2016; 137 (06) 1673-1680
    CrossrefPubMedGoogle Scholar
  • 13 Mihara M, Hara H, Hayashi Y. , et al. Pathological steps of cancer-related lymphedema: histological changes in the collecting lymphatic vessels after lymphadenectomy. PLoS One 2012; 7 (07) e41126
    Google Scholar
  • 14 International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013; 46 (01) 1-11
    PubMedGoogle Scholar
  • 15 Yamamoto T, Yamamoto N, Doi K. , et al. Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns. Plast Reconstr Surg 2011; 128 (04) 941-947
    CrossrefPubMedGoogle Scholar
  • 16 Bottomley A. The cancer patient and quality of life. Oncologist 2002; 7 (02) 120-125
    CrossrefPubMedGoogle Scholar
  • 17 Launois R, Alliot F. Quality of life scale in upper limb lymphoedema – a validation study. Lymphology 2000; 33 (Suppl): 266-274
    PubMedGoogle Scholar
  • 18 Augustin M, Bross F, Földi E, Vanscheidt W, Zschocke I. Development, validation and clinical use of the FLQA-I, a disease-specific quality of life questionnaire for patients with lymphedema. Vasa 2005; 34 (01) 31-35
    CrossrefPubMedGoogle Scholar
  • 19 Penha TR, Botter B, Heuts EM, Voogd AC, von Meyenfeldt MF, van der Hulst RR. Quality of life in patients with breast cancer-related lymphedema and reconstructive breast surgery. J Reconstr Microsurg 2016; 32 (06) 484-490
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Kim SI, Lim MC, Lee JS. , et al. Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection. Eur J Obstet Gynecol Reprod Biol 2015; 192: 31-36
    CrossrefPubMedGoogle Scholar
  • 21 Cornelissen AJM, Kool M, Lopez Penha TR. , et al. Lymphatico-venous anastomosis as treatment for breast cancer-related lymphedema: a prospective study on quality of life. Breast Cancer Res Treat 2017; 163 (02) 281-286
    CrossrefPubMedGoogle Scholar
  • 22 Mihara M, Hara H, Furniss D. , et al. Lymphaticovenular anastomosis to prevent cellulitis associated with lymphoedema. Br J Surg 2014; 101 (11) 1391-1396
    CrossrefPubMedGoogle Scholar
  • 23 Torrisi JS, Joseph WJ, Ghanta S. , et al. Lymphaticovenous bypass decreases pathologic skin changes in upper extremity breast cancer-related lymphedema. Lymphat Res Biol 2015; 13 (01) 46-53
    CrossrefPubMedGoogle Scholar
  • 24 Gennaro P, Gabriele G, Mihara M. , et al. Supramicrosurgical lymphatico-venular anastomosis (LVA) in treating lymphoedema: 36-months preliminary report. Eur Rev Med Pharmacol Sci 2016; 20 (22) 4642-4653
    PubMedGoogle Scholar
  • 25 Chang DW. Lymphaticovenular bypass for lymphedema management in breast cancer patients: a prospective study. Plast Reconstr Surg 2010; 126 (03) 752-758
    CrossrefPubMedGoogle Scholar
  • 26 Mihara M, Hara H, Tange S. , et al. Multisite lymphaticovenular bypass using supermicrosurgery technique for lymphedema management in lower lymphedema cases. Plast Reconstr Surg 2016; 138 (01) 262-272
    CrossrefPubMedGoogle Scholar
  • 27 Carl HM, Walia G, Bello R. , et al. Systematic review of the surgical treatment of extremity lymphedema. J Reconstr Microsurg 2017; 33 (06) 412-425
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Lin CH, Ali R, Chen SC. , et al. Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema. Plast Reconstr Surg 2009; 123 (04) 1265-1275
    CrossrefPubMedGoogle Scholar
  • 29 Cheng MH, Huang JJ, Nguyen DH. , et al. A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle. Gynecol Oncol 2012; 126 (01) 93-98
    CrossrefPubMedGoogle Scholar
  • 30 Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg 2006; 243 (03) 313-315
    CrossrefPubMedGoogle Scholar
  • 31 Sosin M, Yin C, Poysophon P, Patel KM. Understanding the concepts and physiologic principles of lymphatic microsurgery. J Reconstr Microsurg 2016; 32 (08) 571-579
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Penha TR, Ijsbrandy C, Hendrix NA. , et al. Microsurgical techniques for the treatment of breast cancer-related lymphedema: a systematic review. J Reconstr Microsurg 2013; 29 (02) 99-106
    PubMedGoogle Scholar
  • 33 Truong PT, Olivotto IA, Whelan TJ, Levine M. ; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 2004; 170 (08) 1263-1273
    CrossrefPubMedGoogle Scholar
  • 34 Akita S, Nakamura R, Yamamoto N. , et al. Early detection of lymphatic disorder and treatment for lymphedema following breast cancer. Plast Reconstr Surg 2016; 138 (02) 192e-202e
    CrossrefPubMedGoogle Scholar
  • 35 Akita S, Mitsukawa N, Rikihisa N. , et al. Early diagnosis and risk factors for lymphedema following lymph node dissection for gynecologic cancer. Plast Reconstr Surg 2013; 131 (02) 283-290
    CrossrefPubMedGoogle Scholar
  • 36 Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ 2001; 322 (7297): 1297-1300
    Google Scholar